|
|
|
 |
FDA Approval Activities for this Drug…
Primaxin I.M. (imipenem and cilastatin) Injectable Suspension & Primaxin I.V., Merck & Company NDA 50-587/S58 & 50-630/S21 3/4/03 3/10/03 Primaxin I.M. (imipenem and cilastatin) Injectable Suspension & Primaxin I.V., Merck & Company NDA 50-587/S53 & 50-630/S17 11/30/01 2/12/02 Primaxin I.M. (imipenem and cilastatin) Injectable Suspension, Merck & Company NDA 50-638/S015 2/4/99 7/18/01 | Primaxin I.V./imipenem and cilastatin Injection Merck NDA 50-587/S048 PRIMAXIN IM Injectable (Imipenem and Cilastatin), Merck & Co. | PRIMAXIN(tm) IV for Injection (Imipenem and Cilastatin), Merck & Co. | Primaxin I.V. Injection, Merck & Co., Labeling Revision | Primaxin I.M. Injectable Suspension, Merck & Co., Labeling Revision | Primaxin I.M. Injectable Suspension (Imipenem and Cilastatin), Merck & Co., Labeling Revision | Primaxin I.V. (Imipenem and Cilastatin) Injection, Merck & Co., Labeling Revision | Primaxin I.M. (Imipenem and Cilastatin) Injectable Suspension, Merck & Co., Labeling Revision | Primaxin I.M. (imipenem and cilastatin sodium) Injection, Merck & Co., Labeling Revision | Primaxin I.V. (imipenem and cilastatin sodium) Injection, Merck & Co., Labeling Revision | Imipenem and Cilastatin Injection, Hospira, Inc., Approval | Imipenem and Cilastatin, cilastatin sodium; imipenem, Injectable; Injection, Acs Dobfar, Approval
  
|